These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37844003)

  • 1. The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions.
    Faggionato E; Schiavon M; Ekhlaspour L; Buckingham BA; Dalla Man C
    IEEE Trans Biomed Eng; 2024 Mar; 71(3):977-986. PubMed ID: 37844003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the effect of insulin on the disposal of meal-attributable glucose in type 1 diabetes.
    García-García F; Hovorka R; Wilinska ME; Elleri D; Hernando ME
    Med Biol Eng Comput; 2017 Feb; 55(2):271-282. PubMed ID: 27155940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Index of Insulin Sensitivity from Glucose Sensor and Insulin Pump Data: In Silico and In Vivo Validation in Youths with Type 1 Diabetes.
    Schiavon M; Galderisi A; Basu A; Kudva YC; Cengiz E; Dalla Man C
    Diabetes Technol Ther; 2023 Apr; 25(4):270-278. PubMed ID: 36648253
    [No Abstract]   [Full Text] [Related]  

  • 4. A Glucose-Only Model to Extract Physiological Information from Postprandial Glucose Profiles in Subjects with Normal Glucose Tolerance.
    Eichenlaub MM; Khovanova NA; Gannon MC; Nuttall FQ; Hattersley JG
    J Diabetes Sci Technol; 2022 Nov; 16(6):1532-1540. PubMed ID: 34225468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian parameter estimation in the oral minimal model of glucose dynamics from non-fasting conditions using a new function of glucose appearance.
    Eichenlaub MM; Hattersley JG; Gannon MC; Nuttall FQ; Khovanova NA
    Comput Methods Programs Biomed; 2021 Mar; 200():105911. PubMed ID: 33485076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the acute effects of exercise on insulin kinetics in type 1 diabetes.
    Frank S; Jbaily A; Hinshaw L; Basu R; Basu A; Szeri AJ
    J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):829-845. PubMed ID: 30392154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump.
    Schiavon M; Dalla Man C; Kudva YC; Basu A; Cobelli C
    Diabetes Care; 2014; 37(5):1216-23. PubMed ID: 24319120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model.
    Dalla Man C; Caumo A; Basu R; Rizza R; Toffolo G; Cobelli C
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E909-14. PubMed ID: 15972269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluNet: A Deep Learning Framework for Accurate Glucose Forecasting.
    Li K; Liu C; Zhu T; Herrero P; Georgiou P
    IEEE J Biomed Health Inform; 2020 Feb; 24(2):414-423. PubMed ID: 31369390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.
    Dalla Man C; Caumo A; Basu R; Rizza R; Toffolo G; Cobelli C
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E637-43. PubMed ID: 15138152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems.
    Garcia-Tirado J; Zuluaga-Bedoya C; Breton MD
    J Diabetes Sci Technol; 2018 Sep; 12(5):937-952. PubMed ID: 30095007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.
    Hinshaw L; Schiavon M; Dadlani V; Mallad A; Dalla Man C; Bharucha A; Basu R; Geske JR; Carter RE; Cobelli C; Basu A; Kudva YC
    J Clin Endocrinol Metab; 2016 May; 101(5):1954-62. PubMed ID: 26930181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of insulin sensitivity (S I) and glucose effectiveness (S G) from a standardized hyperglucidic breakfast test in type 2 diabetics exhibiting various levels of insulin resistance.
    Brun JF; Ghanassia E; Fédou C; Bordenave S; Raynaud de Mauverger E; Mercier J
    Acta Diabetol; 2013 Apr; 50(2):143-53. PubMed ID: 20981457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bayesian Framework to Identify Type 1 Diabetes Physiological Models Using Easily Accessible Patient Data.
    Cappon G; Facchinetti A; Sparacino G; Favero SD
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():6914-6917. PubMed ID: 31947429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.